FibroGen Inc. Files 2024 Annual Report
Ticker: KYNB · Form: 10-K · Filed: Mar 17, 2025 · CIK: 921299
| Field | Detail |
|---|---|
| Company | Fibrogen Inc (KYNB) |
| Form Type | 10-K |
| Filed Date | Mar 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
FibroGen filed its 2024 10-K. All systems go.
AI Summary
FibroGen Inc. filed its 10-K for the fiscal year ending December 31, 2024, detailing its financial performance and business operations. The company, headquartered in San Francisco, CA, operates in the Pharmaceutical Preparations sector. Key financial data and operational highlights for 2024 are presented in this comprehensive annual report.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of FibroGen's financial health, strategic direction, and potential risks for the past fiscal year.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, FibroGen faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (The report covers the fiscal year ending December 31, 2024.)
- 2025-03-17 — Filing Date (The 10-K was filed on March 17, 2025.)
Key Players & Entities
- FibroGen Inc. (company) — Filer of the 10-K report
- 2024-12-31 (date) — Fiscal year end
- San Francisco, CA (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
- 001-36740 (company_id) — SEC File Number
FAQ
What is FibroGen Inc.'s primary business sector?
FibroGen Inc. operates in the Pharmaceutical Preparations sector, with a Standard Industrial Classification code of 2834.
When did FibroGen Inc. file its 10-K report?
FibroGen Inc. filed its 10-K report on March 17, 2025.
What is the fiscal year end for this 10-K filing?
The fiscal year end for this 10-K filing is December 31, 2024.
Where is FibroGen Inc. headquartered?
FibroGen Inc. is headquartered in San Francisco, CA.
What is the SEC file number for FibroGen Inc.?
The SEC file number for FibroGen Inc. is 001-36740.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 17, 2025 regarding FIBROGEN INC (KYNB).